STOCK TITAN

West to Host Fourth-Quarter and Full-Year 2024 Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

West Pharmaceutical Services (NYSE: WST) has announced its upcoming fourth-quarter and full-year 2024 financial results release, scheduled for Thursday, February 13, 2025, before market opening. The company will host a conference call at 9:00 a.m. Eastern Time to discuss the results and business expectations.

Interested participants can access the live webcast through the company's Investor Relations website. To participate in the Q&A session, advance registration is required, after which participants will receive dial-in details and a unique PIN. A slide presentation will be available in the Investors section on the day of the call. The webcast replay will be accessible for approximately 90 days following the event.

West Pharmaceutical Services (NYSE: WST) ha annunciato il rilascio dei risultati finanziari per il quarto trimestre e l'intero anno 2024, previsto per giovedì 13 febbraio 2025, prima dell'apertura del mercato. L'azienda terrà una teleconferenza alle 9:00 ora orientale per discutere i risultati e le aspettative aziendali.

I partecipanti interessati possono accedere alla trasmissione in diretta tramite il sito web delle Relazioni con gli Investitori dell'azienda. Per partecipare alla sessione di domande e risposte, è necessaria una registrazione anticipata, dopodiché i partecipanti riceveranno i dettagli per la chiamata e un PIN unico. Una presentazione con diapositive sarà disponibile nella sezione Investitori il giorno della chiamata. La registrazione della trasmissione sarà accessibile per circa 90 giorni dopo l'evento.

West Pharmaceutical Services (NYSE: WST) ha anunciado la próxima publicación de sus resultados financieros del cuarto trimestre y del año completo 2024, programada para el jueves 13 de febrero de 2025, antes de la apertura del mercado. La empresa llevará a cabo una conferencia telefónica a las 9:00 a.m. hora del Este para discutir los resultados y las expectativas comerciales.

Los participantes interesados pueden acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores de la compañía. Para participar en la sesión de preguntas y respuestas, se requiere un registro anticipado, tras el cual los participantes recibirán detalles de acceso y un PIN único. También estará disponible una presentación de diapositivas en la sección de Inversores el día de la llamada. La repetición de la transmisión estará accesible durante aproximadamente 90 días después del evento.

웨스트 제약 서비스 (NYSE: WST)가 2024년 4분기 및 연간 재무 결과 발표를 2025년 2월 13일 목요일에 시장 개장 전에 예정하고 있다고 발표했습니다. 회사는 동부 표준시 오전 9시에 결과 및 사업 기대에 대해 논의하기 위한 전화 회의를 개최합니다.

관심 있는 참가자는 회사의 투자자 관계 웹사이트를 통해 실시간 웹캐스트에 액세스할 수 있습니다. 질문 및 답변 세션에 참여하려면 사전 등록이 필요하며, 이후 참가자는 다이얼인 세부 정보와 고유 PIN을 받게 됩니다. 발표 자료는 통화 당일 투자자 섹션에서 제공됩니다. 웹캐스트 재생은 해당 이벤트 이후 약 90일 동안 이용 가능합니다.

West Pharmaceutical Services (NYSE: WST) a annoncé la publication prochaine de ses résultats financiers pour le quatrième trimestre et l'exercice 2024, prévue pour le jeudi 13 février 2025, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 9h00 heure de l'Est pour discuter des résultats et des attentes commerciales.

Les participants intéressés peuvent accéder à la diffusion en direct via le site web des Relations avec les Investisseurs de l'entreprise. Pour participer à la séance de questions-réponses, une inscription préalable est nécessaire, après quoi les participants recevront des détails de connexion et un code PIN unique. Une présentation sera disponible dans la section Investisseurs le jour de l'appel. La rediffusion du webinaire sera accessible pendant environ 90 jours après l'événement.

West Pharmaceutical Services (NYSE: WST) hat die bevorstehende Veröffentlichung der Finanzzahlen für das vierte Quartal und das Gesamtjahr 2024 angekündigt, die für Donnerstag, den 13. Februar 2025, vor Markteröffnung geplant ist. Das Unternehmen wird um 9:00 Uhr Eastern Time eine Telefonkonferenz veranstalten, um die Ergebnisse und Geschäftserwartungen zu besprechen.

Interessierte Teilnehmer können über die Investor-Relations-Website des Unternehmens auf das Live-Webcast zugreifen. Um an der Fragen-und-Antworten-Sitzung teilzunehmen, ist eine vorherige Registrierung erforderlich, nach der die Teilnehmer Anmeldedaten und eine eindeutige PIN erhalten. Eine Präsentation wird am Tag des Anrufs im Bereich Investoren verfügbar sein. Das Webcast-Playback wird ungefähr 90 Tage nach der Veranstaltung zugänglich sein.

Positive
  • None.
Negative
  • None.

EXTON, Pa., Jan. 30, 2025  /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST),  global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 13, 2025, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

The live webcast will be made available via the Company's Investor Relations website or by clicking here.

To ask questions on the conference call, participants need to register in advance by clicking here.  Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call. 

A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the conference call and webcast will be available on the Company's website.  Replay of the webcasts will be available for approximately 90 days after the events.

About West  

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.  

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-fourth-quarter-and-full-year-2024-conference-call-302363473.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When will West Pharmaceutical Services (WST) release its Q4 and full-year 2024 earnings?

West Pharmaceutical Services will release its Q4 and full-year 2024 earnings before the market opens on Thursday, February 13, 2025.

What time is WST's Q4 2024 earnings conference call?

The earnings conference call is scheduled for 9:00 a.m. Eastern Time on February 13, 2025.

How can investors participate in WST's Q4 2024 earnings call?

Investors can participate by accessing the live webcast through the company's Investor Relations website. To ask questions, participants must register in advance to receive dial-in details and a unique PIN.

How long will WST's Q4 2024 earnings call replay be available?

The webcast replay will be available for approximately 90 days after the event on the company's website.

West Pharmaceutical Services, Inc.

NYSE:WST

WST Rankings

WST Latest News

WST Stock Data

25.10B
72.00M
0.59%
96.93%
2.07%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
EXTON